Results · Apr-Jun 2026
JHS Svendgaard Laboratories Q1 FY27 results
Sales grew 30% to ₹30.4 crore from ₹23.5 crore in Apr-Jun 2025.
Operating profit grew 25% to ₹2.1 crore, an operating margin of 6.8% (down 0.3 points from a year ago).
Net profit grew 3% to ₹1.1 crore from ₹1.1 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −7%, net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 30.4 | 23.5 | +30% |
| Operating profit (EBITDA) | 2.1 | 1.7 | +25% |
| Operating margin | 6.8% | 7.1% | −0.3 pts |
| Net profit | 1.1 | 1.1 | +3% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.